Central Pharmaceutical JSC No. 3

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DP36
VND
51,000.00
-300 (-0.58%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About Central Pharmaceutical JSC No. 3 stock-summary
stock-summary
Central Pharmaceutical JSC No. 3
Pharmaceuticals & Biotechnology
Central Pharmaceutical Joint Stock Company No3 (FORIPHARM) is a Vietnam-based company operating in the pharmaceutical industry, which is mainly engaged in the manufacture and trading of pharmaceutical products. The Company's leading products include botanical medicine and other types of drugs, health supplements and cosmetics, among others. Besides, the Company partakes in the commerce of medical equipment and supplies, as well as the conduct of medical research.
Company Coordinates stock-summary
Company Details
So 16 Le Dai Hanh, P. Minh Khai, Q. Hong Bang HAIPHONG None : None
stock-summary
Tel: 84 22 53842576
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Icon
No data for shareholding present.
Shareholding Compare (%holding) stock-summary
Icon
No data for shareholding present.
stock-summary Board of Directorsstock-summary
Management
Designation
Mr. Huong Bui
Chairman of the Board of Management
Mr. Khai Nguyen
General Director, Member of the Board of Management
Mr. Cuong Dinh
Member of the Board of Management
Ms. Nhung Nguyen
Member of the Board of Management
Mr. Tuan Nguyen
Member of the Board of Management
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
94,244 Million
(Quarterly Results - Jun 2025)
Net Profit:
32,099 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

VND 1,102,947 Million (Small Cap)

stock-summary
P/E

9.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

5.85%

stock-summary
Debt Equity

-0.76

stock-summary
Return on Equity

24.20%

stock-summary
Price to Book

2.07